Related Experiment Videos
Intragraft T cell receptor transcript expression in human renal allografts
M Pavlakis1, M L Lipman, T B Strom
1Department of Medicine, Beth Israel Hospital, Harvard Medical School, Boston, MA 02215, USA.
Journal of the American Society of Nephrology : JASN
|August 1, 1995
Summary
Allograft rejection involves a polyclonal T cell infiltration, not limited clones. This study quantifies T cell receptor (TCR) diversity in kidney transplant biopsies, revealing increased TCR V beta families during rejection.
Area of Science:
- Immunology
- Transplantation Science
- Molecular Biology
Background:
- Allograft rejection is a T cell-mediated immune response.
- The specific T cell populations involved in rejection (monoclonal vs. polyclonal) remain unclear.
- Previous studies on T cell receptor (TCR) heterogeneity in rejection have yielded conflicting results.
Purpose of the Study:
- To investigate whether allograft rejection is mediated by a limited number of T cell clones or a polyclonal T cell population.
- To analyze T cell receptor (TCR) heterogeneity in kidney transplant biopsies.
- To correlate TCR diversity with the presence and type of allograft rejection.
Main Methods:
- Utilized reverse transcription-assisted polymerase chain reaction (PCR) on kidney transplant biopsy RNA.
- Quantified T cell infiltration using TCR beta chain constant region (C beta) and glyceraldehyde phosphate dehydrogenase (GAPD) gene expression.
- Examined TCR heterogeneity by amplifying 22 variable region genes of the TCR beta chain (V beta).
Main Results:
- T cell infiltration was significantly higher in acute cellular rejection (ACR) compared to nonrejection (NR).
- The number of intragraft V beta families was elevated in both acute and chronic rejection phases versus nonrejection.
- Serial biopsies showed an increase in intragraft V beta families during progression to immunologic graft loss.
Conclusions:
- Increased numbers of TCR V beta families in rejecting grafts support a polyclonal T cell infiltration hypothesis.
- Clinically apparent allograft rejection is associated with a diverse, polyclonal T cell response.
- This finding has implications for understanding rejection mechanisms and developing targeted therapies.